CVS Health Q2 Results Beat Market, Raises FY25 Adj. EPS View Above Street; Stock Up In Pre-market

(RTTNews) - CVS Health Corp. (CVS), while reporting higher second-quarter results above market estimates, on Thursday lowered fiscal 2025 earnings view on a reported basis, but raised adjusted earnings forecast above the Street.

In the pre-market activity, CVS Health shares were gaining around 9.4 percent to trade at $68.14.

For fiscal 2025, the company now expects earnings per share of $3.84 to $3.94, lower than previously expected $4.23 to $4.43.

However, outlook for adjusted earnings per share have been raised to $6.30 to $6.40 from previous estimate of $6.00 to $6.20.

The Wall Street analysts on average expect the company to report earnings of $6.12 per share. Analysts' estimates typically exclude special items.

The company also raised cash flow from operations guidance to at least $7.5 billion from approximately $7.0 billion expected earlier.

In the second quarter, CVS Health's net profit came in at $1.021 billion or $0.80 per share, compared with $1.770 billion or $1.41 per share last year.

Adjusted earnings were $2.304 billion or $1.81 per share for the period. Analysts had expected the company to earn $1.46 per share.

The company's revenue for the period rose 8.4% to $98.915 billion from $91.234 billion last year. The Street expected revenues of $94.59 billion.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.